Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella-supported patients treated at 109 hospitals in Japan shows a 30-day survival rate of 77% for patients with cardiogenic shock due to myocarditis.
News | Cardiogenic Shock
Multi-Center, Multi-Society Study of Impella-supported Patients with Cardiogenic Shock due to Myocarditis in Japan Achieves 30-day Survival of 77%

September 22, 2022 — Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella ...

Home September 22, 2022
Home
David J. Cohen, MD, MSc, St. Francis Hospital and CRF, presented Jennifer A. Rymer, MD, Duke University Medical Center with the TCT 2022 Thomas J. Linnemeier Young Investigator Award, along with co-presenter Gary S. Mintz of the Cardiovascular Research Foundation (CRF) on Sept 19 in Boston, MA.
News | TCT
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award

September 22, 2022 — The recipient of the TCT 2022 Thomas J. Linnemeier “Spirit of Interventional Cardiology” Young ...

Home September 22, 2022
Home
Medtronic
News | Stents Bifurcation
Medtronic Receives FDA Indication for Bifurcation Percutaneous Coronary Intervention with a Drug-eluting Stent

September 21, 2022 — Medtronic announced today that it has received Food and Drug Administration (FDA) approval for the ...

Home September 21, 2022
Home
EMPOWER CAD is the First Prospective, Female-Only Study of Coronary Interventions
News | Womens Cardiovascular Health
Shockwave Medical Initiates All-Female Coronary IVL Study

September 21, 2022 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat ...

Home September 21, 2022
Home
Over the 10-year span, median cardiology compensation – regardless of ownership model – increased (Figure 1). From 2011 to 2021, private cardiology compensation expanded by 32% to a median of $604,652 per FTE, and integrated cardiology income increased by 13% to $621,596 per FTE.
News | Cardiovascular Business
Cardiology Compensation and New Patient Visits Rebound, Survey Finds

September 21, 2022 — MedAxiom, the premier source for cardiovascular organizational performance solutions, has released ...

Home September 21, 2022
Home
Statistically significant mean reductions of 10.3 mmHg in 24-hour ambulatory systolic blood pressure and 11.7 mmHg in ambulatory pulse pressure after 6 months of therapy in control patients who crossed over to BackBeat CNT following completion of the randomized portion of the MODERATO II study
News | Hypertension
Orchestra BioMed Announces Presentation of Positive Long-Term Clinical Results from MODERATO II Control Patients Crossover Extension Study of BackBeat CNT at TCT 2022

September 20, 2022 — Orchestra BioMed, Inc., a biomedical innovation company accelerating high-impact technologies to ...

Home September 20, 2022
Home
The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population
News | Pediatric Cardiology
Medtronic Receives FDA Clearance for Expanded Indication of LINQ II Insertable Cardiac Monitor For Use in Pediatric Patients Ages 2 and Older

September 20, 2022 — Medtronic, a global leader in healthcare technology, today announced the LINQ II Insertable Cardiac ...

Home September 20, 2022
Home
Results of the CLASP IID Trial Presented at TCT and published simultaneously in JACC: Cardiovascular Interventions
News | Structural Heart
Novel TEER Repair Device Meets Primary Endpoint in Treating Degenerative Mitral Regurgitation in Patients Not Eligible for Surgery

September 20, 2022 — Results of the first randomized controlled trial to directly compare two contemporary transcatheter ...

Home September 20, 2022
Home
Results from TVT registry analysis presented at TCT and published simultaneously in the Journal of the American College of Cardiology
News | Cardiogenic Shock
STS/ACC TVT Registry Analysis Assesses Use of Transcatheter Edge-to-Edge Repair in Severe Mitral Regurgitation and Cardiogenic Shock

September 20, 2022 — An analysis from the Society of Thoracic Surgeons/American College of Cardiology(STS/ACC) TVT ...

Home September 20, 2022
Home
The TCT 2022 Innovation Shark Tank Competition award presentation was held Sept. 19, in Boston, MA. Shown here announcing the winner, Puzzle Medical Devices, are Robert Schwartz, MD, and Juan F. Granada, President and CEO of the Cardiovascular Research Foundation (CRF).
News | TCT
TCT 2022 Announces Winner of Shark Tank Innovation Award

September 19, 2022 — Puzzle Medical Devices, a provider of hemodynamic support in Heart Failure (HF), was selected as ...

Home September 20, 2022
Home
FIH study demonstrated feasibility and safety of cardiorenal support among patients undergoing high-risk PCI
News | Heart Failure
First-in-Human Study Finds Mechanical Circulatory Support and Renal Perfusion Success with the ModulHeart Device

September 19, 2022 — A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has ...

Home September 19, 2022
Home
Patent Opens Pathway to a Disruptive Ischemia and Arrhythmia Detection ECG Patch Product
News | Advances in Cardiac ECG Monitoring Technologies
HeartBeam Granted Patent for 12-Lead Electrocardiogram (ECG) Patch Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias

September 19, 2022 — HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only ...

Home September 19, 2022
Home
Dr. Gagan Singh, Dr. Susheel Kodali, and Dr. Azeem Latib with principal investigator, Dr. Adrian Ebner, following the initial first-in-human cases with the Supira System.
News | Cardiogenic Shock
Supira Medical Announces Successful First-in-Human Use of its Next Generation Percutaneous Ventricular Assist Device

September 19, 2022 — Supira Medical, Inc., a Shifamed portfolio company focused on developing the next-generation ...

Home September 19, 2022
Home
Results also demonstrate the benefits for patients of Abbott's TriClip™ for tricuspid regurgitation, Amulet™ for atrial fibrillation and Portico™ for aortic stenosis
News | Structural Heart
Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies

September 17, 2022 — Abbott today announced data from five late-breaking presentations showing the benefits of its ...

Home September 17, 2022
Home
Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets
News | Structural Heart
First-ever Comparison of MicroCT and Histology in Self-expanding Transcatheter Aortic Valve Replacement Patients with Hypo-attenuated Leaflet Thickening

September 17, 2022 — Medtronic today announced findings from its Pathological Study of Hypo-Attenuated Leaflet ...

Home September 17, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now